Human Papillomavirus Vaccine in Patients with Systemic Lupus Erythematosus
Authors:
- Carla CarnovaleCCCarla Carnovale
- Valentina PerroneVPValentina Perrone
- Dionigi SalvatiDSDionigi Salvati
- Marta GentiliMGMarta Gentili
- Stefania AntoniazziSAStefania Antoniazzi
- Emilio ClementiECEmilio Clementi
- Sonia RadiceSRSonia Radice
- 1 January 2014
- journal article
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 25 (1) , 155-156
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case–control studyAnnals of the Rheumatic Diseases, 2013
- Human papillomavirus vaccine and systemic lupus erythematosusClinical Rheumatology, 2013
- The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approachesExpert Review of Vaccines, 2013
- EULAR recommendations for vaccination in paediatric patients with rheumatic diseasesAnnals of the Rheumatic Diseases, 2011
- HPV infection and cervical disease: A reviewAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2011
- High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patientsArthritis Care & Research, 2007